| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ablation of Soft Tissue (eg, Radiofrequency Coblation, Ultrasonic Ablation) for Musculoskeletal ConditionsPayerPolicy · ARKBLUE-ABLATION-OF-SOFT-TISSUE-EG-RADIOFREQUENCY-COBLATION-ULTRASONIC-ABLATION-FOR-MUSCULOSKELETAL-CONDITIONS | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Abatacept (e.g., Orencia)PayerPolicy · ARKBLUE-ABATACEPT-E-G-ORENCIA | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sirolimus protein-bound particles for injectable suspension (e.g., Fyarro)PayerPolicy · ARKBLUE-SIROLIMUS-PROTEIN-BOUND-PARTICLES-FOR-INJECTABLE-SUSPENSION-E-G-FYARRO | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Sebelipase alfa (e.g., Kanuma)PayerPolicy · ARKBLUE-SEBELIPASE-ALFA-E-G-KANUMA | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Radioembolization of Primary & Metastatic Tumors of the LiverPayerPolicy · ARKBLUE-RADIOEMBOLIZATION-OF-PRIMARY-METASTATIC-TUMORS-OF-THE-LIVER | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lutetium Lu 177 Dotatate (e.g., Lutathera)PayerPolicy · ARKBLUE-LUTETIUM-LU-177-DOTATATE-E-G-LUTATHERA | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel SyndromePayerPolicy · ARKBLUE-PERCUTANEOUS-ELECTRICAL-NERVE-FIELD-STIMULATION-1FCFE861B1 | New policy |
|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Genetic Test: Hereditary Diffuse Gastric Cancer (CDH1, CTNNA1)PayerPolicy · ARKBLUE-GENETIC-TEST-HEREDITARY-DIFFUSE-GASTRIC-CANCER-CDH1-CTNNA1 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Zolbetuximab-clzb (Vyloy)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-181 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Zenocutuzumab-zbco (Bizengri)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-183 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Zanidatamab-hrii (Ziihera)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-182 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | X-rays Associated with Fractures in the Office SettingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-031 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Bioengineered Skin SubstitutesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-015 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Wheelchair Options and AccessoriesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-046 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Wheelchair Cushions and SeatingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-023 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | WalkersPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-037 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Voretigene Neparvovec-rzyl (Luxturna)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-094 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Vitamin D Assay TestingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-031 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ventricular Assist Devices (VADs)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-011 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Velmanase alfa (Lamzede)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-147 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Vedolizumab (Entyvio) for Injection for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-001 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Vagus Nerve Stimulation (VNS)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-019 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ustekinumab for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-042L-FB7F3D389D | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Use of a Robotic-Assisted Surgical SystemPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-057 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Urological SuppliesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-054 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Upper-Limb ProsthesesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-057 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-023 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ultraviolet Light Therapy for the Treatment of Dermatological ConditionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-002 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ublituximab-xiiy (Briumvi ) for intravenous usePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-160 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tumor Treating FieldsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-032 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Trilaciclib (Cosela)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-134 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Trigger Point InjectionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-017 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Triamcinolone Acetonide ER Injectable (Zilretta)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-097 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatments for Complex Regional Pain Syndrome (CRPS)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-026N-FA11A0184F | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Varicose Veins of the Lower Extremities and Perforator Vein IncompetencePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-001 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic AgentsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-016 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in AdultsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-047 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Obesity and Bariatric Surgery for Treatment of Morbid ObesityPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-051 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Treatment of Medical and Surgical ComplicationsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-050 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Trastuzumab (Herceptin) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-018 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Transcutaneous Electrical Nerve Stimulators (TENS) and Associated SuppliesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-006 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Transcatheter Cardiac Valve ProceduresPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-027 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Transcatheter Arterial Chemoembolization (TACE) of Hepatic MalignanciesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-040 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tracheostomy Care SuppliesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-034 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Total Parenteral Nutrition (TPN) / Intradialytic Parenteral Nutrition (IDPN)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-008 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Toripalimab-tpzi (Loqtorzi)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-170 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tocilizumab and Related Biosimilars for Intravenous Infusion and Subcutaneous InjectionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-045Q-15811C2D8A | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tisotumab vedotin-tftv (Tivdak)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-141 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tislelizumab-jsgr (Tevimbra)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-173 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tildrakizumab-asmn (Ilumya)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-098A-B6C7B88389 | New policy |
|---|